Home > Science & Mathematics > Biology, life sciences > Microbiology (non-medical) > Courage to Face Covid-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex
35%
Courage to Face Covid-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex

Courage to Face Covid-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex

          
5
4
3
2
1

International Edition


Premium quality
Premium quality
Bookswagon upholds the quality by delivering untarnished books. Quality, services and satisfaction are everything for us!
Easy Return
Easy return
Not satisfied with this product! Keep it in original condition and packaging to avail easy return policy.
Certified product
Certified product
First impression is the last impression! Address the book’s certification page, ISBN, publisher’s name, copyright page and print quality.
Secure Checkout
Secure checkout
Security at its finest! Login, browse, purchase and pay, every step is safe and secured.
Money back guarantee
Money-back guarantee:
It’s all about customers! For any kind of bad experience with the product, get your actual amount back after returning the product.
On time delivery
On-time delivery
At your doorstep on time! Get this book delivered without any delay.
Quantity:
Add to Wishlist

About the Book

The story of doctors who developed a safe and effective early treatment for COVID-19 and their battle with the Bio-Pharmaceutical Complex that suppressed it.

At the beginning of 2020, Dr. Peter McCullough was a highly regarded practicing physician, program director, teacher, and clinical investigator at a major academic medical center in Dallas, Texas. When COVID-19 arrived in March, he felt a duty to find a treatment for the disease. He wasn't alone. Other doctors all over the world were also searching for a cure. They followed the longstanding principle that it's best to tackle a sickness early, before it becomes life threatening. This is the story of how Dr. McCullough and his colleagues developed an early treatment protocol of generic, repurposed drugs and supplements that has saved millions of COVID-19 patients from hospitalization and death.

In spite of their success, their early treatment protocol was not welcomed by public health officials. On the contrary, the news of their promising results was dismissed as soon as it was reported. At first this seemed like conventional skepticism, but then fraudulent papers maligning the protocol's repurposed drugs were published in academic medical journals. This and other acts of fraud revealed that a coordinated smear campaign against early treatment was being waged. Dr. McCullough and his colleagues soon found themselves censured, censored, attacked in the media, and fired from their jobs. The greatest victims of the smear campaign were COVID-19 patients who were consequently deprived of early treatment. Hundreds of thousands needlessly died of the disease.

At the same time early treatment was suppressed, the US government and mainstream media proclaimed that the cure to COVID-19 lay in a new generation of vaccines that were being developed at warp speed. These were heralded as a forthcoming panacea that would save mankind and restore normalcy. As soon as they were mass deployed, public health officials would lift the restrictions on social and economic life.

While many observers were thunderstruck by this turn of events, there were historical precedents. In his 1961 Farewell Address, President Eisenhower warned: We must guard against the acquisition of unwarranted influence, whether sought of unsought, by the military-industrial complex. The potential for the disastrous rise of misplaced power exists and will persist. We must never let the weight of this combination endanger our liberties or democratic processes. As Dr. McCullough and his colleagues learned, Eisenhower's warning has become equally applicable to the Bio-Pharmaceutical Complex of multinational drug companies, the NIH and other federal agencies, research and virology labs, and the Gates Foundation. Since COVID-19 arrived, this Complex has obtained misplaced power over every aspect of our lives and taken our liberties. The Courage to Face Covid-19 recounts how Dr. McCullough and his colleagues began their work by fighting a novel infectious disease, and then became leaders in fighting the tyrannical regime that endangers our American way of life.


Best Sellers



Product Details
  • ISBN-13: 9781510776807
  • Publisher: Skyhorse Publishing
  • Publisher Imprint: Skyhorse Publishing
  • Height: 231 mm
  • No of Pages: 288
  • Spine Width: 33 mm
  • Weight: 458 gr
  • ISBN-10: 151077680X
  • Publisher Date: 22 Nov 2022
  • Binding: Hardback
  • Language: English
  • Returnable: Y
  • Sub Title: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex
  • Width: 155 mm


Similar Products

How would you rate your experience shopping for books on Bookswagon?

Add Photo
Add Photo

Customer Reviews

REVIEWS           
Click Here To Be The First to Review this Product
Courage to Face Covid-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex
Skyhorse Publishing -
Courage to Face Covid-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex
Writing guidlines
We want to publish your review, so please:
  • keep your review on the product. Review's that defame author's character will be rejected.
  • Keep your review focused on the product.
  • Avoid writing about customer service. contact us instead if you have issue requiring immediate attention.
  • Refrain from mentioning competitors or the specific price you paid for the product.
  • Do not include any personally identifiable information, such as full names.

Courage to Face Covid-19: Preventing Hospitalization and Death While Battling the Bio-Pharmaceutical Complex

Required fields are marked with *

Review Title*
Review
    Add Photo Add up to 6 photos
    Would you recommend this product to a friend?
    Tag this Book
    Read more
    Does your review contain spoilers?
    What type of reader best describes you?
    I agree to the terms & conditions
    You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.

    CUSTOMER RATINGS AND REVIEWS AND QUESTIONS AND ANSWERS TERMS OF USE

    These Terms of Use govern your conduct associated with the Customer Ratings and Reviews and/or Questions and Answers service offered by Bookswagon (the "CRR Service").


    By submitting any content to Bookswagon, you guarantee that:
    • You are the sole author and owner of the intellectual property rights in the content;
    • All "moral rights" that you may have in such content have been voluntarily waived by you;
    • All content that you post is accurate;
    • You are at least 13 years old;
    • Use of the content you supply does not violate these Terms of Use and will not cause injury to any person or entity.
    You further agree that you may not submit any content:
    • That is known by you to be false, inaccurate or misleading;
    • That infringes any third party's copyright, patent, trademark, trade secret or other proprietary rights or rights of publicity or privacy;
    • That violates any law, statute, ordinance or regulation (including, but not limited to, those governing, consumer protection, unfair competition, anti-discrimination or false advertising);
    • That is, or may reasonably be considered to be, defamatory, libelous, hateful, racially or religiously biased or offensive, unlawfully threatening or unlawfully harassing to any individual, partnership or corporation;
    • For which you were compensated or granted any consideration by any unapproved third party;
    • That includes any information that references other websites, addresses, email addresses, contact information or phone numbers;
    • That contains any computer viruses, worms or other potentially damaging computer programs or files.
    You agree to indemnify and hold Bookswagon (and its officers, directors, agents, subsidiaries, joint ventures, employees and third-party service providers, including but not limited to Bazaarvoice, Inc.), harmless from all claims, demands, and damages (actual and consequential) of every kind and nature, known and unknown including reasonable attorneys' fees, arising out of a breach of your representations and warranties set forth above, or your violation of any law or the rights of a third party.


    For any content that you submit, you grant Bookswagon a perpetual, irrevocable, royalty-free, transferable right and license to use, copy, modify, delete in its entirety, adapt, publish, translate, create derivative works from and/or sell, transfer, and/or distribute such content and/or incorporate such content into any form, medium or technology throughout the world without compensation to you. Additionally,  Bookswagon may transfer or share any personal information that you submit with its third-party service providers, including but not limited to Bazaarvoice, Inc. in accordance with  Privacy Policy


    All content that you submit may be used at Bookswagon's sole discretion. Bookswagon reserves the right to change, condense, withhold publication, remove or delete any content on Bookswagon's website that Bookswagon deems, in its sole discretion, to violate the content guidelines or any other provision of these Terms of Use.  Bookswagon does not guarantee that you will have any recourse through Bookswagon to edit or delete any content you have submitted. Ratings and written comments are generally posted within two to four business days. However, Bookswagon reserves the right to remove or to refuse to post any submission to the extent authorized by law. You acknowledge that you, not Bookswagon, are responsible for the contents of your submission. None of the content that you submit shall be subject to any obligation of confidence on the part of Bookswagon, its agents, subsidiaries, affiliates, partners or third party service providers (including but not limited to Bazaarvoice, Inc.)and their respective directors, officers and employees.

    Accept

    New Arrivals



    Inspired by your browsing history


    Your review has been submitted!

    You've already reviewed this product!